Most Leqvio (inclisiran) side effects are mild and short-lived, typically resolving within days of the injection. The most common reaction is irritation at the injection site, which clinical trial data consistently describes as “transient.” Because Leqvio clears from your bloodstream within 24 to 48 hours, side effects tied directly to the drug tend to fade quickly, even though the cholesterol-lowering effect lasts for months.
Why Side Effects Are Short but the Drug Works Long
Leqvio works differently from most medications. It’s a small piece of genetic material (called small interfering RNA) that gets absorbed into liver cells and silences the gene responsible for producing a protein called PCSK9, which raises LDL cholesterol. The drug itself has a plasma half-life of only about 5 to 7 hours, meaning it’s virtually undetectable in your blood within one to two days after injection. But inside the liver, it keeps working for roughly six months, which is why you only need two doses per year after the initial loading phase.
This disconnect matters for side effects. Because the drug leaves your circulation so quickly, most reactions that stem from the injection itself, like soreness, redness, or mild swelling at the site, tend to resolve in a matter of days. The drug’s long duration of action in the liver doesn’t translate into prolonged side effects for most people.
Injection Site Reactions
The single most commonly reported side effect is a reaction where the needle went in. In the four-year ORION-3 extension study, about 14% of patients experienced injection site reactions over the course of the trial. These reactions are generally described as mild to moderate, and the word that comes up repeatedly in the clinical literature is “transient.” They rarely lead anyone to stop treatment. In clinical trials, only a very small percentage of patients discontinued Leqvio because of injection site discomfort.
Typical symptoms include redness, pain, or a small area of swelling around the injection site. While exact day-by-day resolution timelines aren’t published in the FDA prescribing information, the pattern mirrors other injectable medications given under the skin: most people see improvement within two to three days, and nearly all reactions clear within a week. Applying a cool compress and avoiding rubbing the area can help ease discomfort in the meantime.
Other Reported Side Effects
Beyond the injection site, clinical trials identified a few side effects that occurred slightly more often in people receiving Leqvio than those receiving a placebo:
- Joint pain: reported in 5% of Leqvio patients versus 4% on placebo
- Urinary tract infections: 4.4% versus 3.6% on placebo
- Bronchitis: 4.3% versus 2.7% on placebo
The small differences between the Leqvio and placebo groups are worth noting. Joint pain, for example, occurred in only about 1% more patients on Leqvio than on placebo, which means some of these symptoms may not be caused by the drug at all. The FDA prescribing information does not include specific data on how many days or weeks these particular side effects lasted, but none are described as chronic or long-term complications of treatment.
Do Side Effects Change Over Time?
Leqvio follows an unusual dosing schedule: you get your first injection, a second one at three months, and then one every six months after that. A reasonable concern is whether side effects get worse with repeated doses. The four-year ORION-3 study offers some reassurance here. Over the full study period, serious adverse events possibly related to the drug were reported in just 1% of patients. The study’s overall conclusion was that twice-yearly Leqvio was “well tolerated over 4 years,” with no signal that side effects accumulated or worsened over time.
The published trial data does not break down whether injection site reactions are more or less intense at the second or third dose compared to the first. Anecdotally, some patients report milder reactions as they continue treatment, but this hasn’t been formally studied.
How Leqvio Compares to Other PCSK9 Treatments
Before Leqvio, the main alternatives for people who needed powerful LDL reduction beyond statins were injectable antibody treatments like evolocumab (Repatha) and alirocumab (Praluent), which require injections every two to four weeks. Leqvio’s safety profile has been found comparable to these older options, with no major serious adverse events standing out in head-to-head analyses. The practical advantage is frequency: fewer injections per year means fewer opportunities for injection site reactions overall, even if any single injection carries a similar chance of local irritation.
When Side Effects May Need Attention
Because Leqvio is cleared from your bloodstream within about two days, any side effect that persists well beyond a week, or that feels severe rather than mildly annoying, is worth bringing up with your healthcare provider. Serious adverse events in clinical trials were rare, occurring in roughly 1% of patients over four years, and allergic reactions are possible but uncommon. If you develop signs of an allergic reaction like rash, itching, or difficulty breathing shortly after your injection, that warrants immediate medical attention rather than a wait-and-see approach.
For the vast majority of people, the practical answer is straightforward: expect mild soreness at the injection site for a few days, and don’t be surprised if you notice nothing at all.